Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
about
Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to combination long-acting beta 2 -agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta 2 -agonists (LABA) for adults with asthmaLong-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthmaCombined aclidinium bromide and long-acting beta 2 -agonist for COPDLong-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthmaMolecular Regulation of Toll-like Receptors in Asthma and COPDTiotropium in asthma: what is the evidence and how does it fit in?Muscarinic antagonists in early stage clinical development for the treatment of asthma.The evidence on tiotropium bromide in asthma: from the rationale to the bedside.The M3 muscarinic receptor is required for optimal adaptive immunity to helminth and bacterial infection.Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease.Defective Resensitization in Human Airway Smooth Muscle Cells Evokes β-Adrenergic Receptor Dysfunction in Severe AsthmaEfficacy and Safety of an Aclidinium Bromide Treatment for 12 Weeks or Longer in Patients with Moderate-To-Severe COPD: A Meta-Analysis.Phytochemica: a platform to explore phytochemicals of medicinal plants.Targeting phosphoinositide 3-kinase γ in airway smooth muscle cells to suppress interleukin-13-induced mouse airway hyperresponsiveness.Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.Safety and tolerability of inhalational anticholinergics in COPDA role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.Medical emergencies: pulmonary embolism and acute severe asthma.Emerging role of long acting muscarinic antagonists for asthmaClinical potential of aclidinium bromide in chronic obstructive pulmonary diseaseAnticholinergics/antimuscarinic drugs in asthma.Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical use.Non-neuronal cholinergic system in airways and lung cancer susceptibility.Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to dateBronchoprotective tolerance with indacaterol is not modified by concomitant tiotropium in persistent asthma.Possible role for anisodamine in organophosphate poisoning.Step 4: stick or twist? A review of asthma therapy.Tiotropium for the treatment of asthma in adolescents.Sphingosine 1-Phosphate: A Novel Target for Lung Disorders.Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.Special issue of BJP on respiratory pharmacology.Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.Step 4: stick or twist? A review of asthma therapy.Airway Relaxation Effects of Water-Soluble Sclerotial Extract From Lignosus rhinocerotis.Evaluation of different anti-asthmatic drugs on cooling-induced bronchoconstriction
P2860
Q24186370-58AD94F3-60C1-489A-8238-0B63EDF4719CQ24186406-6C7F26F7-7633-4A8E-BB84-00D36AF90A60Q24187031-12508B9B-AF49-4C29-9081-4BD6632F65BFQ24187322-2C688908-0F7E-4D08-B350-B45F9E189BC4Q24187595-A8B25EA3-B9D0-4BA7-8BED-3CC1BC8AD455Q24187613-B49329F3-D27A-4219-BF1D-51DAC57FD35FQ24188162-DD2F8A7E-DF40-4194-B835-50347CDAA100Q26776173-7948AECE-8153-47C6-B763-1E6170336951Q28067912-4D74AEE9-44D5-4E77-8CFE-41ED8F66FEA7Q30396144-A3085592-D896-4A5A-8437-48181E84479CQ33644971-C0A2463E-D7C8-41B6-8955-C1B095DC52CEQ35023656-DCE7B569-7BB8-406C-8A81-AA066647E281Q35135970-9B5A6522-AFF5-4484-B3BA-6ED8A65F2A13Q35645970-9E62E34E-6746-48F0-AE0C-5E350F748969Q35914818-70D37275-E89F-4CD3-BFDB-7867C57581F5Q35930304-C3C41E41-F542-437C-A75D-D005D88928C5Q36105368-BBA220FF-D99E-4B13-9FEF-177AB7803B0EQ36432415-F0484F82-A3E0-480E-9588-CFA1FA33571BQ36680246-D9B5D0F4-467D-4A7C-8A99-98D282ADE24DQ37624342-0F39A824-4740-4506-BB74-2F67149AE54CQ38064909-B2CD524B-454B-4A74-8143-53D5725401E4Q38093655-ED388098-641E-47F6-B571-8FD0C4463403Q38223379-A34530A3-441E-47E5-9F32-6EFF6A4468B5Q38256783-8BDDC0EB-8037-41B0-856F-19B11178B36EQ38258030-E4E1F4D8-CA28-40EF-AD41-3DCC1B58D3BDQ38390054-92730400-8CAE-4EB7-A3E2-77C43B4BC622Q38432438-58BDCFCC-E5DE-45F6-874E-29EC8AD6D0D5Q38700260-2CBBDA61-8273-4D54-898B-0041494F424BQ38787139-5F8409C1-4BAA-4B3B-BBAE-759A3EDAA34FQ38960423-B7C785C7-C2AF-4E0D-9B6C-7E0840CD745AQ39007200-AD068C16-C781-4686-BDB5-0DC37A8189E0Q39205808-BC12C230-4B8F-4517-9A2E-BC5E38E81901Q40090191-1F4390D5-796D-4E97-819A-B20FB0AFBF33Q42725432-BA6DFEC5-687E-42CB-920A-DD096F3C45A5Q44633127-7D1EDE43-580F-41F7-8541-EDFF42CA44FEQ47102804-36181AFA-82F9-4752-A112-680F3E660F7BQ47946666-541692F3-A58F-47F2-A16F-341065541D7CQ54887789-4140403E-C451-4B41-96CA-EBD6B15C3FF2Q55344462-DC29C33B-39B5-4502-AC84-2BA670E48968Q57112567-1072234F-F860-41A9-AFB0-05B7D2E05A88
P2860
Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@ast
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@en
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@nl
type
label
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@ast
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@en
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@nl
prefLabel
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@ast
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@en
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@nl
P2860
P921
P1476
Muscarinic receptor antagonist ...... ually work in asthma and COPD.
@en
P2093
Bart C Moulton
P2860
P356
10.1111/J.1476-5381.2010.01190.X
P407
P577
2011-05-01T00:00:00Z